ArticleFrontiers in endocrinology2022

Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients.

Sara Krogh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.